公司概覽
業務類別 Biotechnology
業務概覽 Satellos Bioscience Inc is a regenerative medicine company a biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.
公司地址 200 Bay Street, Suite 2800, Royal Bank Plaza, South Tower, Toronto, ON, CAN, M5J 2J1
電話號碼 +1 905 336-6128
傳真號碼 --
公司網頁 https://www.satellos.com
員工數量 27
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Michael Rudnicki, F.R.S. Chief Discovery Officer -- 26/03/2025
Ms. Courtney Wells Senior Vice President, Clinical Development Operations -- 26/03/2025
Mr. Frank Gleeson President, Chief Executive Officer and Director -- 20/05/2025
Mr. Warren Whitehead Head of Corporate Strategy -- 16/04/2024
Dr. Philip Lambert, PhD Chief Scientific Officer -- 20/05/2025
Ms. Elizabeth Williams, C.A.,C.P.A. Chief Financial Officer -- 20/05/2025
 
董事會成員
董事會 職務 更新日期
Mr. Geoff Mackay Chairman of the Board 20/05/2025
Dr. Iris Loew-Friedrich Independent Director 20/05/2025
Mr. Frank Gleeson President, Chief Executive Officer and Director 20/05/2025
Mr. Brian Bloom Director 20/05/2025
Dr. Selwyn Ho, M.B.B.S. Independent Director 20/05/2025
Mr. Adam S. Mostafa Independent Director 20/05/2025
Mr. Franklin M. Berger, C.F.A. Independent Director 20/05/2025
Ms. Stephanie L. Brown Independent Director 20/05/2025
 
所屬ETF (更新日期: 07/03/2026 03:57)
代號 名稱 佔比% 持有日期
SURISimplify Propel Opportunities ETF0.02%27/02/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.